Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 1,511 shares at $2.69 ($4K) on 2026-04-30, disclosed to the SEC on 2026-05-01.
Open-market purchase of $4k PCSA by Chief Business - Strategy Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PCSA | BUY | 2026-06-01 | $4K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $4K | — | Filing → |
| PCSA | BUY | 2026-04-17 | $4K | — | Filing → |